Related Experiment Video
Updated: Jul 19, 2026
11:36
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Autoimmune liver disease
1Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA. czaja.albert@mayo.edu
Current Opinion in Gastroenterology
|October 13, 2006
Summary
Autoimmune hepatitis in children may co-occur with sclerosing cholangitis. Researchers identified potential biomarkers and genetic factors influencing autoimmune hepatitis, exploring new treatment options like mycophenolate mofetil.
Area of Science:
- Hepatology
- Immunology
- Genetics
Background:
- Autoimmune hepatitis (AIH) can present with overlapping features of other liver diseases, complicating diagnosis and management.
- Wilson disease shares clinical and laboratory similarities with AIH, potentially responding initially to corticosteroids.
- Genetic factors and specific antibodies are implicated in AIH pathogenesis and disease expression.
Purpose of the Study:
- To investigate the association of AIH with sclerosing cholangitis in children without inflammatory bowel disease.
- To identify potential biomarkers for AIH clinical activity and treatment response.
- To explore the role of genetic polymorphisms and specific autoantibodies in AIH susceptibility and phenotype.
Main Methods:
- Clinical and laboratory data analysis of pediatric and adult patients.
- Assessment of soluble HLA-DR antigens as markers of disease activity.
- Investigation of cytotoxic T lymphocyte antigen-4 gene polymorphisms and DRB1*1301.
- Analysis of antibodies to soluble liver antigen/liver-pancreas and CYP2D6.
- Evaluation of antineutrophil cytoplasmic antibodies and the efficacy of mycophenolate mofetil.
Main Results:
- AIH in children can be associated with sclerosing cholangitis independently of inflammatory bowel disease.
- Soluble HLA-DR antigens correlate with clinical activity and may predict treatment response.
- Specific HLA alleles (DRB1*1301) may define unique patient subgroups.
- Antibodies to soluble liver antigen/liver-pancreas and CYP2D6 have been characterized.
- Impaired activation-induced cell death is suggested in AIH, with mycophenolate mofetil showing promise in difficult cases.
Conclusions:
- AIH in children may present with unique associations, such as sclerosing cholangitis.
- Soluble HLA-DR and specific gene polymorphisms are relevant to AIH activity and susceptibility.
- Further research into autoantibody targets and novel therapeutic agents like mycophenolate mofetil is warranted for autoimmune hepatitis management.
Related Concept Videos
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:17Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...